Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gardani

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Tumori|November 24, 1998
Interventional radiology and radiotherapy for inoperable cholangiocarcinoma of the extrahepatic bile ductsM Milella, M Salvetti, A Cerrotta, et al.
Neuro Endocrinology Letters|May 4, 2001
Efficacy of monochemotherapy with docetaxel (taxotere) in relation to prolactin secretion in heavily pretreated metastatic breast cancerP Lissoni, M Vaghi, A Ardizzoia, et al.
La Radiologia Medica|October 1, 1981
[Radiological diagnosis in 229 cases of breast fibroadenoma]G Coopmans De Yoldi, A Guzzon, S Bergonzi, et al.
Tumori|February 28, 1981
Usefulness of chest and skeletal survey to assess the time of relapse in breast cancerJ D Tesoro-Tess, P Valagussa, G Gardani, et al.
Anticancer Research|June 25, 2003
Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinationsG Cerea, M Vaghi, A Ardizzoia, et al.
Journal of Biological Regulators and Homeostatic Agents|March 25, 2005
Biological response modifiers of cancer-related neuroendocrine disorders: efficacy of the long-term dopaminergic agonist cabergoline in the treatment of breast cancer-induced hyperprolactinemiaP Lissoni, M Vaghi, S Pescia, et al.
La Radiologia Medica|July 1, 1992
[The results of definitive transcutaneous radiotherapy in the treatment of oropharyngeal neoplasms]G Gardani, F Valvo, R Kenda, et al.
La Radiologia Medica|July 1, 1995
[Transcutaneous radiotherapy combined with low dose intraluminal brachytherapy in the treatment of non-operable neoplastic stenoses of the bile ducts]S Tana, A Di Russo, A Cerrotta, et al.
The International Journal of Biological Markers|May 23, 2006
Chromogranin A blood concentrations in relation to those of prolactin in hormone-refractory metastatic prostate cancer: possible existence of two independent mechanisms responsible for endocrine resistanceP Lissoni, P ViganĂ², A Podraska, et al.
Minerva Medica|November 27, 2008
Efficacy of HT 7 point acupressure stimulation in the treatment of insomnia in cancer patients and in patients suffering from disorders other than cancerR Cerrone, L Giani, B Galbiati, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Tumori|November 24, 1998
Interventional radiology and radiotherapy for inoperable cholangiocarcinoma of the extrahepatic bile ductsM Milella, M Salvetti, A Cerrotta, et al.
Neuro Endocrinology Letters|May 4, 2001
Efficacy of monochemotherapy with docetaxel (taxotere) in relation to prolactin secretion in heavily pretreated metastatic breast cancerP Lissoni, M Vaghi, A Ardizzoia, et al.
La Radiologia Medica|October 1, 1981
[Radiological diagnosis in 229 cases of breast fibroadenoma]G Coopmans De Yoldi, A Guzzon, S Bergonzi, et al.
Tumori|February 28, 1981
Usefulness of chest and skeletal survey to assess the time of relapse in breast cancerJ D Tesoro-Tess, P Valagussa, G Gardani, et al.
Anticancer Research|June 25, 2003
Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinationsG Cerea, M Vaghi, A Ardizzoia, et al.
Journal of Biological Regulators and Homeostatic Agents|March 25, 2005
Biological response modifiers of cancer-related neuroendocrine disorders: efficacy of the long-term dopaminergic agonist cabergoline in the treatment of breast cancer-induced hyperprolactinemiaP Lissoni, M Vaghi, S Pescia, et al.
La Radiologia Medica|July 1, 1992
[The results of definitive transcutaneous radiotherapy in the treatment of oropharyngeal neoplasms]G Gardani, F Valvo, R Kenda, et al.
La Radiologia Medica|July 1, 1995
[Transcutaneous radiotherapy combined with low dose intraluminal brachytherapy in the treatment of non-operable neoplastic stenoses of the bile ducts]S Tana, A Di Russo, A Cerrotta, et al.
The International Journal of Biological Markers|May 23, 2006
Chromogranin A blood concentrations in relation to those of prolactin in hormone-refractory metastatic prostate cancer: possible existence of two independent mechanisms responsible for endocrine resistanceP Lissoni, P ViganĂ², A Podraska, et al.
Minerva Medica|November 27, 2008
Efficacy of HT 7 point acupressure stimulation in the treatment of insomnia in cancer patients and in patients suffering from disorders other than cancerR Cerrone, L Giani, B Galbiati, et al.
Pageof 6